Literature DB >> 6306270

Chromosome integration domain for bovine leukemia provirus in tumors.

R Kettmann, J Deschamps, D Couez, J J Claustriaux, R Palm, A Burny.   

Abstract

The 3'-end host-virus junction fragments from two bovine leukemia virus (BLV)-induced lymphoid tumors (tumors 15-4 and 1351), each containing a single provirus, were used as probes to detect large restriction fragments flanking these proviruses. The DNAs from 28 other independent BLV-induced tumors were checked by Southern analysis of their restriction fragments for possible rearrangement due to the insertion of a BLV provirus in the cellular sequences corresponding to those flanking the proviruses in tumors 15-4 and 1351. In no case did proviral integration occur in cellular sequences corresponding to those implicated in the tumors of origin. According to the statistical analysis performed, if a preferential domain for BLV integration exists, it has a size of 1,304 kilobases when the probability of not observing an integration event in the cellular fragments considered in tumors 15-4 and 1351 is 0.50.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306270      PMCID: PMC255216     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species.

Authors:  J Deschamps; R Kettmann; A Burny
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

5.  Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.

Authors:  W S Hayward; B G Neel; S M Astrin
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

6.  Restriction endonuclease mapping of linear unintegrated proviral DNA of bovine leukemia virus.

Authors:  R Kettmann; D Couez; A Burny
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

7.  The isolation of structural genes from libraries of eucaryotic DNA.

Authors:  T Maniatis; R C Hardison; E Lacy; J Lauer; C O'Connell; D Quon; G K Sim; A Efstratiadis
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

8.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

9.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

10.  Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences.

Authors:  R Kettmann; J Deschamps; Y Cleuter; D Couez; A Burny; G Marbaix
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

  10 in total
  16 in total

1.  Proviral detection and serology in bovine leukemia virus-exposed normal cattle and cattle with lymphoma.

Authors:  R M Jacobs; Z Song; H Poon; J L Heeney; J A Taylor; B Jefferson; W Vernau; V E Valli
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

2.  The pX region of the bovine leukemia virus is transcribed as a 2.1-kilobase mRNA.

Authors:  R Z Mamoun; T Astier-Gin; R Kettmann; J Deschamps; N Rebeyrotte; B J Guillemain
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  Identification and some biochemical properties of the major XBL gene product of bovine leukemia virus.

Authors:  N Sagata; J Tsuzuku-Kawamura; M Nagayoshi-Aida; F Shimizu; K Imagawa; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

4.  Different bovine leukemia virus-induced tumors harbor the provirus in different chromosomes.

Authors:  D Grégoire; D Couez; J Deschamps; S Heuertz; M C Hors-Cayla; J Szpirer; C Szpirer; A Burny; G Huez; R Kettmann
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

5.  Nucleotide sequence analysis of the long terminal repeat of integrated bovine leukemia provirus DNA and of adjacent viral and host sequences.

Authors:  D Couez; J Deschamps; R Kettmann; R M Stephens; R V Gilden; A Burny
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

6.  Role of the 3' long open reading frame region of bovine leukemia virus in the maintenance of cell transformation.

Authors:  R Kettmann; Y Cleuter; D Gregoire; A Burny
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

7.  Bovine leukemia virus: unique structural features of its long terminal repeats and its evolutionary relationship to human T-cell leukemia virus.

Authors:  N Sagata; T Yasunaga; Y Ogawa; J Tsuzuku-Kawamura; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 8.  Reflections on viruses and cancer.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

9.  Integration of bovine leukaemia virus at all stages of enzootic bovine leukosis.

Authors:  J Coulston; R C Daniel; M F Lavin
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Characterization of cellular sequences flanking an integrated bovine leukemia virus genome.

Authors:  E P Gelmann; A Burny; R Kettmann
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.